Filter
104
Text search:
Moderna
vaccine
Featured
Recommendations
14
Language
Document type
Fact sheets
30
Studies & Reports
27
Guidelines
22
Manuals
6
Resource Platforms
5
Training Material
4
Online Courses
3
Infographics
2
Strategic & Response Plan
2
No document type
2
Videos
1
Countries / Regions
Germany
9
Ukraine
5
Argentina
4
Middle East and North Africa
4
Paraguay
4
China
3
Brazil
3
Russia
3
Global
3
Colombia
2
Ecuador
2
Latin America and the Carribbean
2
Guinea-Bissau
1
Ghana
1
Haiti
1
Philippines
1
Kenya
1
South Africa
1
Mozambique
1
Angola
1
Chile
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Western and Central Europe
1
Africa
1
Eastern Europe
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
43
Clinical Guidelines
3
Key Resources
3
Annual Report MEDBOX
1
Public Health
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
89
Refugee
3
Conflict
2
Health Financing Toolbox
2
Rapid Response
1
TB
1
Pharmacy
1
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage exist
...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to finance equitable access in 92 lower-income countries. Si
...
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in
...
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec
...
This presentation presents the issues we confront in deciding how to communicate to the public that COVID-19 vaccine recommendations reflect the state of scientific knowledge.
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic
...
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
interim guidance, 19 July 2021 (arabic version)
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key informat
...
Vaccinator's Manual. MODERNA Vaccine
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
A rapid evidence briefing. Vaccinated people are less likely to develop long COVID, even if they get infected, a rapid review of 15 studies by the UK Health Security Agency shows.
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do
...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian
...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci
...
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases
...
